Your browser doesn't support javascript.
loading
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
Léger, Jean-Marc; De Bleecker, Jan L; Sommer, Claudia; Robberecht, Wim; Saarela, Mika; Kamienowski, Jerzy; Stelmasiak, Zbigniew; Mielke, Orell; Tackenberg, Björn; Shebl, Amgad; Bauhofer, Artur; Zenker, Othmar; Merkies, Ingemar S J.
Affiliation
  • Léger JM; Reference Center for Rare Neuromuscular Diseases, Hôpital Pitié-Salpêtrière and University Paris VI, Paris, France. jean-marc.leger@psl.aphp.fr
J Peripher Nerv Syst ; 18(2): 130-40, 2013 Jun.
Article in En | MEDLINE | ID: mdl-23781960
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulins, Intravenous / Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Immunologic Factors Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Peripher Nerv Syst Journal subject: NEUROLOGIA Year: 2013 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulins, Intravenous / Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Immunologic Factors Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Peripher Nerv Syst Journal subject: NEUROLOGIA Year: 2013 Document type: Article Affiliation country: France Country of publication: United States